ArticleDiagnostics (Basel, Switzerland)2026
Can Tc-99m-PSMA SPECT/CT Be Used as Accessible Alternative for Diagnosis of Biochemically Recurrent Prostate Cancer? A Prospective Study.
Veljković Miloš, Beatović Slobodanka, Pejčić Tomislav, Bukumirić Zoran, Odalović Strahinja, Grozdić Milojević Isidora, Stojiljković Milica, Petrović Jelena, Ivanovski Ana, Šobić Šaranović Dragana and 1 more
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Veljković MilošCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-8463-5932 Beatović SlobodankaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Pejčić TomislavFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Odalović StrahinjaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Grozdić Milojević IsidoraCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-3301-9456 Stojiljković MilicaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-7170-4433 Petrović JelenaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-7168-8848 Ivanovski AnaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0000-3993-7114 Šobić Šaranović DraganaCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-9600-090X Artiko VeraCenter for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-6078-4500 Funding
Ministry of Science, Technological developments and Innovations of Republic of Serbia. 451-03-137/2025-03/ 200110
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biochemical recurrenceprostate cancerTc-99m-PSMA SPECT/CT
Identifiers
PMID41897628
PMCPMC13025446
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390